Basel, 23 April 2019 Roche launches new VENTANA HER2 Dual ISH companion diagnostic test for breast and gastric cancer patients eligible for targeted therapy Nearly 2.1 million new cases of breast cancer are diagnosed worldwide each year, and more than 620,000 people will die from the disease.1 About 15 to 20 percent of women diagnosed... Read more
Agilent Receives an Expanded FDA Approval for its Companion Diagnostic in NSCLC PD-L1 IHC 22C3 pharmDx Can Now Be Used to Identify a Broader Range of NSCLC Patients for First-line Treatment With KEYTRUDA® (pembrolizumab) SANTA CLARA, Calif., April 16, 2019 Agilent Technologies Inc. (NYSE: A) today announced that the U.S. Food and Drug Administration has... Read more
Nijmegen, Netherlands, April 16, 2019 – At the opening event of the Netherlands X-omics Initiative, Bruker and the Translation Metabolic Laboratory (TML) at Radboud University Medical Center (UMC) today jointly announce the establishment of a Center of Excellence (CoE) for Translational Omics. Under the leadership of Professor Alain van Gool, the joint CoE will focus on... Read more
Boston, MA – April 8, 2019 – GE Healthcare today announced Edison will integrate with ACR AI-LAB. The Edison platform helps accelerate the development and adoption of Artificial Intelligence (AI) technology and empower providers to deliver faster, more precise care. Edison serves as a “digital thread” for GE Healthcare’s existing AI partnerships and products, and... Read more
Germantown, Maryland, and Hilden, Germany, April 12 2019 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the U.S. launch of its novel therascreen® FGFR RGQ RT-PCR Kit (therascreen FGFR Kit) as a companion diagnostic to help guide the use of the newly approved FGFR kinase inhibitor, BALVERSA™ (erdafitinib), developed by Janssen Biotech,... Read more
The Rigaku Progeny ResQ 1064 nm handheld Raman analyzer will be deployed globally as part of the U.S. Army’s Dismounted Reconnaissance Sets, Kits, and Outfits (DRSKO) Program Wilmington, MA (April 2, 2019) – Rigaku Analytical Devices, a U.S.-based, leading pioneer of handheld and portable spectroscopic analyzers, is pleased to announce they will provide the Rigaku... Read more
New Expanded Analytical Instrument Portfolio of U.S. FDA Class I Medical Devices for Clinical Diagnostic Laboratories Thermo Scientific Medical Device portfolio provides an extensive range of chromatography and mass spectrometry instruments for laboratory development test optimization PALM SPRINGS, Calif., April 1, 2019 /PRNewswire/ — MSACL US 2019 – Thermo Fisher Scientific announces the expansion of its portfolio... Read more
By John Burchell / March 25, 2019 Home / News / New Center for Spectroscopic Excellence JASCO Corporation (Tokyo Japan) is proud to announce a joint collaboration with the Department of Chemistry at the prestigious University of Pennsylvania (Philadelphia). The New Center for Spectroscopic Excellence was inaugurated at the end of March 2019. We are pleased to be working with the researchers... Read more
Serological testing plays critical role in helping diagnose patients with celiac disease WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that its EUROIMMUN Anti-TissueTransglutaminase (tTG) ELISA has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The test system is designed to help clinicians confirm or exclude... Read more
March 20, 2019 Shimadzu Corporation (head office: Kyoto city; President and CEO: Teruhisa Ueda) announces the release of a Multi-Omic Data Analysis Package designed for metabolic engineering research applications. Using this package, measurement data from Shimadzu mass spectrometers can be loaded in the Garuda*1 open platform and automatically plotted on a metabolic map. The package can... Read more